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1. INTRODUCTION 
An unusual heat-stable form of alkaline phos- 
phatase (ALP) that closely resembles human pla- 
cental ALP in its immunologic characteristics has 
been found to occur in substantial mounts in lung 
from certain Old World monkeys [1]. In Ouchter- 
lony double diffusion plates using rabbit anti- 
serum raised against purified human placental 
ALP, the Old World monkey lung ALPs give pre- 
cipitin lines continuous with that given by human 
placental ALP and with no detectable spurring. 
However, these ALPs can be sharply distinguished 
from human placental ALP and indeed from other 
human and non-human primate ALPs by their rel- 
ative sensitivities to certain amino acid and tripep- 
tide inhibitors [1]. The purpose of this work was to 
probe the immunochemical haracteristics of these 
ALPs further, by using a series of monoclonal nti- 
bodies raised against human placental ALP and 
known to be directed at a series of different anti- 
genic sites on the surface of the ALP molecule 
[2,3]. Two different methods were used. The first 
involves electrophoretic separation of enzyme/ 
antibody complexes from uncomplexed enzyme. 
The second is based on assays of enzyme activity 
in immobilized enzyme/antibody complexes. A 
distinctive immunochemical profile differentiating 
these ALPs from human placental ALP was ob- 
tained. 
2. METHODS 
Enzyme extraction and assay of human placen- 
tal ALP and heat-stable (65°C, l h) lung ALP 
from Rhesus monkey, baboon, pig-tailed macaque 
and Java monkey were carried out as described in 
[1]. Production and characterization of the 18 
monoclonal ntibodies used has been described in 
[2,3]. Polyacrylamide g l electrophoresis and ALP 
staining of the ALP before and after reaction with 
monoclonal ntibody was carried out as in [4]. 
ALP assay of immobilized enzyme/antibody 
complexes was performed as follows: 100~1 
i/2000 rabbit anti-mouse Ig (Cdppel) diluted in 
phosphate-buffered saline (PBS, pH7.4) was 
placed in each well of a 96-well, V-bottomed poly- 
vinyl microtiter plate and allowed to stand for 2 h. 
The wells were then emptied and refilled to the top 
with 0.5% bovine serum albumin (BSA) in 0.01 M 
diethanolamine, 0.9% NaC1, to block residual pro- 
tein-binding sites on the plastic. After standing for 
30 min, the plate was washed twice with BSA in 
PBS. Hybridoma culture fluid (40#1) was then 
added to each well and incubated overnight at 4°C 
to allow immobilization of the monoclonal anti- 
body. The plate was washed twice with BSA in 
PBS. ALP (100/d) diluted to 0.5 IU/ml in 0.5% 
BSA/PBS was then added to each well. After 
standing overnight at 4°C to allow binding of en- 
zyme to immobilized monoclonal antibody, the 
plate was washed 6 times in Tris-HC1 (pH 7.4) 
containing 0.9% NaC1. ALP substrate solution 
(100 ~1; 5 mM p-nitrophenylphosphate, 1.0 M di- 
ethanolamine (pH 9.8), 0.28 M NaCI, 0.5 mM 
MgCI2) was added to each well and incubated at 
30°C for 30 min. The reaction was stopped by ad- 
dition of 100 ~1 0.5 N NaOH. Reaction mixture 
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(100/xl) from each well was then transferred to a 
flat-bottomed E.1.A. microtiter plate (Flow Labs.) 
and the A405 read in a Titertek Multiscan appara- 
tus (Flow Labs.). On each microtiter plate, 4 anti- 
bodies were tested against 3 lung ALPs and the 
control human placental ALP (type 1), each run in 
triplicate. Individual blanks were obtained by re- 
placing substrate solution by buffer, and the whole 
plate was zeroed against substrate solution stopped 
at zero time. The reactivity of a particular lung 
ALP relative to the reactivity of human placental 
lung ALP with a particular monoclonal antibody, 
was determined by dividing the mean absorbance 
for the test sample by the mean absorbance for the 
human placental sample with the same antibody 
on the same plate. This procedure for estimating 
relative reactivity (RR) was adopted so as to mini- 
mize plate-to-plate variation. 
3. RESULTS 
In the electrophoretic system, binding of a par- 
ticular antibody to a particular ALP is demon- 
strated by the disappearance of the zone of activity 
corresponding to that seen in the absence of anti- 
body and the appearance of slower migrating 
zones corresponding to the enzyme/antibody com- 
plexes [5]. With the control human placental ALP 
type 1, this effect was observed with all 18 anti- 
bodies. With the same procedure, all 4 Old World 
monkey lung ALPs were found to bind to 10 of the 
antibodies, and with 3 other antibodies the ALP 
from at least 2 of the lung ALPs from the 4 species 
showed binding. The remaining 5 antibodies ap- 
peared to be unreactive with the Old World 
monkey ALPs by this test. In those cases where no 
enzyme binding was detected, activity of the ALP 
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Fig.l. Reactivities of heat-stable ung ALPs from 4 Old World monkeys relative to human placental ALP (RR-values) 
with 18 monoclonal ntibodies raised against human placental ALP. 
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Fig.2. Correlation of RR-values for heat-stable lung 
ALPs from baboon and from pig-tailed macaque with 
18 monoclonal antibodies raised against human 
placental ALP. 
was unchanged after incubation with antibody. 
The reactivities of the various lung ALPs rela- 
tive to the reactivity of placental ALP with the 18 
different antibodies estimated by the plate assay 
(RR determination) are shown in fig.l. There is a 
wide range of RR-values. Some show reactivities 
very similar to those obtained with human placen- 
tal ALP (RR ~ 1.0). Others show virtually no 
cross-reactivity (RR < 0.1). The majority show in- 
termediate l vels of cross-reactivity. All the lung 
ALP:monoclonal antibody combinations which 
showed no apparent binding in the electrophoretic 
system gave RR < 0.1, the majority being close to 
zero. In general, there is a good correlation be- 
tween the RR-values for the lung ALPs from the 4 
Old World monkey species with the 18 monoclonal 
antibodies. This is illustrated for baboon and pig- 
tailed macaque in fig.2. However, there are occa- 
sional exceptions where with a particular antibody, 
a marked difference in cross-reactivity is seen with 
the lung ALP from different species. Thus in fig.2, 
one antibody gives an RR of 0.6 for pig-tailed 
macaque, but a value close to zero for baboon. 
Other examples are seen in fig.2. 
The results show how the close immunologic 
similarity of the thermo-stable Old World monkey 
lung ALPs with human placental ALP, originally 
detected with polyclonal antisera, can be dissected 
using a panel of monoclonal antibodies. Each 
monoclonal antibody is thought o bind to an anti- 
genic determinant that represents a small region 
on the enzyme surface made up of just a few not 
necessarily sequential amino acids. The Old World 
monkey lung ALPs and human placental ALP 
may be presumed to have evolved from a common 
ancestral form, the differences in structure they 
now exhibit being the consequence of point muta- 
tions (amino acid substitutions, etc.) which oc- 
curred in the course of their divergent evolutions. 
Cross-reactivity with a given monoclonal antibody 
implies that the antigenic determinant in human 
placental ALP, against which the antibody was 
raised, is represented in the Old World monkey 
ALP, though perhaps with modifications derived 
from structural changes in evolution. The relative 
degree of cross-reactivity provides an indication of 
the extent of such structural differences. The wide 
variation in RR-values indicates the degree to 
which the structures of different determinant sites 
have been modified. Those antibodies that show 
strong cross-reactivity with each of the Old World 
monkey lung ALPs are presumably directed to 
antigenic determinant sites that have been rela- 
tively highly conserved in evolution. 
The generally high correlation of the RR-values 
for the different monoclonal antibodies among the 
ALPs from the 4 Old World monkey species indi- 
cates that they share common immunologic and 
therefore structural characteristics that distinguish 
them from human placental ALP. However, de- 
partures from this common reactivity profile, in 
that with a given antibody, the ALP from one of 
the species may cross-react strongly and from an- 
other only weakly or not at all, do occur. These ex- 
ceptions indicate structural changes in the particu- 
lar determinant region that have occurred in the 
separate volutions of the four related species, or 
are polymorphic within the species. The fact that 
in those cases where very little or no antibody 
binding was detected in the quantitative study, the 
ALP in the electrophoretic study after incubation 
with the particular antibody showed no change in 
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activity from its control, indicates that the low RR- 
values in these cases cannot be attributed to inhibi- 
tion of enzyme activity by the antibody. 
In general, the results show the potential value 
of quantitative studies with a panel of monoclonal 
antibodies in investigations on enzyme volution. 
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